We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2014 by University Hospital, Ghent.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00367406
First Posted: August 22, 2006
Last Update Posted: December 5, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University Hospital, Ghent
August 21, 2006
August 22, 2006
December 5, 2014
November 2006
July 2015   (Final data collection date for primary outcome measure)
Consolidation of the fracture [ Time Frame: From surgery untill healing ]
Consolidation of the fracture
Complete list of historical versions of study NCT00367406 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison Between Gamma 3 Nail and ACE Trochanteric Nail
Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

Pertrochanteric and subtrochanteric femur fractures will be treated with a Gamma 3 nail or an ACE Trochanteric nail.

Following topics will be assessed: fracture consolidation, mobility, pain, walking power, agility.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Pertrochanteric and Subtrochanteric Femur Fractures
Device: Gamma 3 nail versus ACE trochanteric nail
Comparing Gamma 3 nail versus ACE trochanteric nail
Experimental: Treatment with a Gamma 3 nail.
Intervention: Device: Gamma 3 nail versus ACE trochanteric nail
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
100
July 2015
July 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pertrochanteric or subtrochanteric femur fracture
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT00367406
2006/280
No
Not Provided
Not Provided
University Hospital, Ghent
University Hospital, Ghent
Not Provided
Principal Investigator: René Verdonk, MD, PhD University Hospital, Ghent
University Hospital, Ghent
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP